The latest biotech news

News and Trends 5 Mar 2015

Baxter’s Bioscience Business Acquires SuppreMol

Baxter has acquired SuppreMol for €200M before working capital and other adjustments. The acquisition includes SuppreMol’s early-stage development portfolio of novel biologic immunoregulatory therapeutics for the treatment of autoimmune diseases.…

March 5, 2015 - 2 minutesmins - By Lourdes Riquelme

Bavarian Nordic Bristol Myers Squibb cancer

News and Trends 4 Mar 2015

Bristol-Myers Squibb signs an agreement for Bavarian Nordic’s PROSTVAC

Bristol-Myers Squibb signs an exclusive agreement with Bavarian Nordic for PROSTVAC, a prostate-specific antigen-targeting cancer immunotherapy. Bavarian Nordic will receive up to €880.4M. Bristol-Myers Squibb will have the exclusive option…

March 4, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 4 Mar 2015

Boehringer Ingelheim submits applications for approval of Idarucizumab, an anti-anticoagulant

Boehringer Ingelheim submitted idarucizumab for approval of marketing authorization to the European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA) and Health Canada. The submission is directed to patients who…

March 4, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 4 Mar 2015

Alkermes presents its new treatment of Alzheimer’s agitation

Alkermes reveals a new drug candidate, ALKS 7119, for treatment of Alzheimer’s agitation, depression and other central nervous system (CNS) diseases. Alkermes has successfully completed preclinical development and expects to…

March 4, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 3 Mar 2015

ICON Completes the Acquisition of MediMedia Pharma Solutions

ICON plc completed the acquisition of MediMedia Pharma Solutions, creating the industry’s leading integrated market access solution. Headquartered in Dublin, ICON plc is a global provider of drug development solutions…

March 3, 2015 - 1 minutemin - By Lourdes Riquelme

News and Trends 3 Mar 2015

Calixar Raises €1 Million to License-out its Isolation Technologies

CALIXAR, develops new approaches to isolate in solution - with the highest purity levels - full-length membrane antigens and proteins, whilst keeping their structural and functional integrity. The company announced…

March 3, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 2 Mar 2015

Monsanto Reaffirms its Commitment in Europe

While the "Salon International de l'Agriculture 2015" has just closed its doors in Paris, Monsanto, a global provider of leading technology solutions and products that improves farm productivity, reaffirms its…

March 2, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 28 Feb 2015

The biotechnologies applied to the veterinary science, the markets by 2018

France was the first country where the veterinary studies have become institutionalized through the establishment of the first veterinary schools in the eighteenth century. Veterinary science is vital to the…

February 28, 2015 - 5 minutesmins - By Cédric Brock

News and Trends 27 Feb 2015

Sanofi: Get Ready for the Launch of the First Inhaled Insulin in the U.S.

Sanofi, the global healthcare leader has core strengths in the field of healthcare due to its seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal…

February 27, 2015 - 3 minutesmins - By Joachim Eeckhout

Orca Pharmaceuticals AstraZeneca autoimmune2

News and Trends 27 Feb 2015

Orca Pharmaceuticas Associates with AstraZeneca to Identify Best-in-Class RORγ Inhibitors

Orca Pharmaceuticals, and AstraZeneca embarked on a three year collaboration to develop inhibitors of retinoic acid-related orphan nuclear receptor gamma (RORγ). Inhibitors of this receptor are believed to have potential…

February 27, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 26 Feb 2015

SSB’s Ambr Bioreactor Systems Enhanced with Software for Design of Experiments

The French company, Sartorius Stedim Biotech (SSB), announced that the 2015 version of the Ambr systems (Ambr 15 and Ambr 250) will be supplied with integrated BioPAT MODDE Software for…

February 26, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 26 Feb 2015

Celltrion launches world’s first biosimilar monoclonal antibody in 12 new European markets

Celltrion Healthcare has today announced the launch of Remsima (infliximab) in 12 European markets: Austria, Belgium, Denmark, France, Germany, Greece, Italy, Luxembourg, the Netherlands, Spain, Sweden and the UK. The…

February 26, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 26 Feb 2015

Unstoppable Ferring after the Acquisition of a novel Oral Drug Delivery Technology

Ferring Pharmaceuticals signed an agreement with South Korean CTCBIO to acquire rights to a novel oral drug delivery technology. The Swiss company is growing more and more rapidly with plenty…

February 26, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 25 Feb 2015

Ipsen buys an option to Acquire Canbex

Canbex, a spin-off of University College London (UCL) that raised a Series A financing of €2.8M in 2013 from MS Ventures, may become part of Ipsen. The French giant payed…

February 25, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 25 Feb 2015

Cellectis is preparing its IPO in the U.S

Cellectis is a company focused on developing immunotherapies based on gene edited engineered CAR-T cells. The company’s mission is to develop a new generation of cancer therapies based on engineered…

February 25, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 24 Feb 2015

Cobra Biologics and Manchester University Awarded €296.4K

The University of Manchester and Cobra Biologics, biologics and pharmaceuticals manufacturer, have been awarded €296.4K by Innovate UK and the Biotechnology and Biological Sciences Research Council (BBSRC). The project is…

February 24, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 23 Feb 2015

Adimab, the secret weapon of the Big Pharma companies

After establishing discovery collaborations with over 30 companies during the past five years (Roche, Pfizer, Genentech, Novartis, Merck, Lilly, Celgene, Novo Nordisk and GSK), it is today with Sanofi that…

February 23, 2015 - 2 minutesmins - By Cédric Brock

News and Trends 22 Feb 2015

Theravectys: an Orphan Drug Designation for Its Lentiviral Vector-Based Therapeutic Vaccine

THERAVECTYS, a fully-integrated discovery and clinical development biotechnology company focusing on the development of therapeutic vaccines and immunotherapy, announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation to its therapeutic vaccine candidate for the…

February 22, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 21 Feb 2015

Succesfull Phase II for Novo Nordisk’s new diabetes treatment

Good news for diabetes mellitus type 2 patients, as Novo Nordisk announced positive results for phase II trial with oral semaglutide. Novo Nordisk successfully completed the phase II trial for…

February 21, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 20 Feb 2015

GNA Biosolutions Leads the Consortium for Ultra-Fast Detection of Ebola

The ultra-fast diagnostic instruments developer, GNA Biosolutions (GNA), started the FILODIAG (Filovirus Diagnostics) project for developing a high-speed Ebola detection system based on GNA’s novel Laser PCR technology. There is…

February 20, 2015 - 3 minutesmins - By Lourdes Riquelme

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering

Outsourcing in life science R&D today

Changing the Partner Discovery Game with Connect for Biotech

Looking to expand your network?

Subscribe to our newsletter to get the latest biotech news!